(Q27009231)

3

0 references

Marco Segatto

object named as

Marco Segatto

2

0 references

Valentina Pallottini

object named as

Valentina Pallottini

4

0 references

author name string

Laura Trapani

1

1 reference

language of work or name

1 reference

November 2011

1 reference

1 reference

63

1 reference

PubMed

issue

11

1 reference

PubMed

page(s)

964-71

1 reference

Being well-informed about statin is associated with continuous adherence and reaching targets

PubMed

cites work

1 reference

Statin-induced apoptosis and skeletal myopathy

21 January 2018

1 reference

The safety of statins in clinical practice

21 January 2018

1 reference

Accelerated ageing: from mechanism to therapy through animal models

21 January 2018

1 reference

Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.

21 January 2018

1 reference

Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders

21 January 2018

1 reference

Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells

21 January 2018

1 reference

Cholesterol: from feeding to gene regulation

21 January 2018

1 reference

Ezetimibe: cholesterol lowering and beyond

21 January 2018

1 reference

21 January 2018

1 reference

Regulation of sterol synthesis in eukaryotes.

21 January 2018

1 reference

Perspectives of the non-statin hypolipidemic agents

21 January 2018

1 reference

Structural mechanism for statin inhibition of HMG-CoA reductase

21 January 2018

1 reference

Pharmacogenetic study of statin therapy and cholesterol reduction

21 January 2018

1 reference

Hypercholesterolemia and 3-hydroxy-3-methylglutaryl coenzyme A reductase regulation in aged female rats

21 January 2018

1 reference

Statin-associated muscle-related adverse effects: a case series of 354 patients

21 January 2018

1 reference

Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis

21 January 2018

1 reference

Structure and regulation of mammalian squalene synthase

21 January 2018

1 reference

Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential

21 January 2018

1 reference

Effect of YM-53601, a novel squalene synthase inhibitor, on the clearance rate of plasma LDL and VLDL in hamsters

21 January 2018

1 reference

Pharmacological approaches to modifying HDL: more basic science to understand HDL metabolism is necessary. Editorial to: "NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrop

21 January 2018

1 reference

Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells: a new type of potent squalene epoxidase inhibitors

21 January 2018

1 reference

Squalene epoxidase and oxidosqualene lanosterol-cyclase activities in cholesterogenic and non-cholesterogenic tissues.

21 January 2018

1 reference

Transcriptional regulation of squalene epoxidase by sterols and inhibitors in HeLa cells

21 January 2018

1 reference

The transcriptional program in the response of human fibroblasts to serum

21 January 2018

1 reference

Squalene epoxidase as hypocholesterolemic drug target revisited

21 January 2018

1 reference

Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells

21 January 2018

1 reference

Galloyl esters from rhubarb are potent inhibitors of squalene epoxidase, a key enzyme in cholesterol biosynthesis

21 January 2018

1 reference

The monotopic membrane protein human oxidosqualene cyclase is active as monomer

21 January 2018

1 reference

Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors

21 January 2018

1 reference

Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear

21 January 2018

1 reference

Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.

21 January 2018

1 reference

A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content

21 January 2018

1 reference

Minimal amidine structure for inhibition of nitric oxide biosynthesis

21 January 2018

1 reference

Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity

21 January 2018

1 reference

Structure activity relationships of new inhibitors of mammalian 2,3-oxidosqualene cyclase designed from isoquinoline derivatives

21 January 2018

1 reference

U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases

21 January 2018

1 reference

Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor

21 January 2018

1 reference

Toxicologic lesions associated with two related inhibitors of oxidosqualene cyclase in the dog and mouse

21 January 2018

1 reference

Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes

21 January 2018

1 reference

Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux

21 January 2018

1 reference

Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol

21 January 2018

1 reference

release_ly3bhgjnvbagdmincvvc4aaylm

21 January 2018

Identifiers

DOI

10.1002/IUB.522

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ly3bhgjnvbagdmincvvc4aaylm